DUODART 0.5 MG/0.4 MG CAP 30 S

Duodart is indicated for the treatment of patients with moderate-to-severe symptoms of Benign Prostatic Hyperplasia (BPH). It reduces the risk of acute urinary retention (AUR) and the need for BPH-related surgery by reducing prostate size, improving urinary flow and alleviating symptoms.

Directions to use :

as directed by the physician

Side effects :

dizziness, light-headedness and potential fainting due to a sudden drop in blood pressure upon standing up (orthostatic hypotension)